Cellebrite DI Ltd. (CLBT) P/E Ratio History
Historical price-to-earnings valuation from 2021 to 2025
Loading P/E history...
Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of March 1, 2026, Cellebrite DI Ltd. (CLBT) trades at a price-to-earnings ratio of 43.0x, with a stock price of $13.34 and trailing twelve-month earnings per share of $0.31.
The current P/E is 31% above its 5-year average of 32.8x. Over the past five years, CLBT's P/E has ranged from a low of 4.7x to a high of 73.0x, placing the current valuation at the 56th percentile of its historical range.
Compared to the Technology sector median P/E of 25.2x, CLBT trades at a 71% premium to its sector peers. The sector includes 345 companies with P/E ratios ranging from 0.0x to 199.1x.
The PEG ratio of 0.73 (P/E divided by 123% EPS growth) suggests the stock may be undervalued relative to its earnings growth. Peter Lynch popularized the rule that a PEG below 1.0 indicates an attractive entry point.
Relative to the broader market, CLBT commands a significant premium over the S&P 500 median P/E of 26.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our CLBT DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
Peer Comparison
P/E metrics vs. Data platforms, integration and analytics peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
PLTRPalantir Technologies Inc. | $313B | 217.8 | - | +232%Best |
CLBTCellebrite DI Ltd. | $3B | 43.0 | 0.73Best | +123% |
TDCTeradata Corporation | $3B | 27.1Lowest | - | +90% |
AVPTAvePoint, Inc. | $2B | 71.9 | - | +194% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
Historical P/E Data
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q4 | Wed Dec 31 2025 00:00:00 GM | $18.03 | $0.31 | 58.3x | +78% |
| FY2025 Q3 | $18.53 | $0.31 | 60.4x | +84% | |
| FY2023 Q1 | Fri Mar 31 2023 00:00:00 GM | $6.09 | $0.12 | 52.2x | +59% |
| FY2022 Q4 | Sat Dec 31 2022 00:00:00 GM | $4.36 | $0.62 | 7.1x | -78% |
| FY2022 Q3 | Fri Sep 30 2022 00:00:00 GM | $3.92 | $0.83 | 4.7x | -86% |
| FY2022 Q2 | $5.10 | $0.75 | 6.8x | -79% | |
| FY2022 Q1 | $6.40 | $0.62 | 10.3x | -69% | |
| FY2021 Q4 | Fri Dec 31 2021 00:00:00 GM | $8.02 | $0.36 | 22.2x | -32% |
| FY2021 Q3 | $9.26 | $0.13 | 73.0x | +123% |
Average P/E for displayed period: 32.8x
See CLBT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CLBT Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare CLBT vs NVDA
See how CLBT stacks up against sector leader NVIDIA Corporation.
Start ComparisonFrequently Asked Questions
Is CLBT stock overvalued or undervalued?
CLBT trades at 43.0x P/E, above its 5-year average of 32.8x. The 56th percentile ranking indicates a premium to historical valuation.
How does CLBT's valuation compare to peers?
Cellebrite DI Ltd. P/E of 43.0x compares to sector median of 25.2x. The premium reflects expected growth above peers.
What is CLBT's PEG ratio?
CLBT PEG ratio is 0.73. Below 1.0 indicates valuation is supported by earnings growth rate. Historical P/E data spans 2021-2025.